Skip to main content

Search

Study Title Study Sponsor Status Study Drug Trial Phase Study Protocol Number Site
Transthyretin Amyloidosis Outcomes Survey (THAOS): A Global, Multi-Center, Longitudinal, Observational Survey of Patients With Documented Transthyretin Gene Mutations or Wild-Type Transthyretin Amyloidosis Pfizer Terminated Tafamidis 4 B3461001 King Faisal Specialist Hospital and Research Center (Riyadh)
A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Mitapivat in Subjects With Sickle Cell Disease Agios Pharmaceuticals, Inc. Ongoing Mitapivat 2/3 AG348-C-020 King Khalid University Hospital (Riyadh)
Prospective, observational study in sickle cell disease patients on crizanlizumab treatment in Middle East countries and India. Novartis Ongoing crizanlizumab 4 CSEG101AIC05 Prince Mohammad Bin Naser Hospital, Jizan, Saudi Arabia
A PHASE II, SINGLE-ARM STUDY OF ATEZOLIZUMAB IN PATIENTS WITH LOCALLY ADVANCED, UNRESECTABLE STAGE III NON-SMALL CELL LUNG CANCER WHO HAVE NOT PROGRESSED AFTER PLATINUM-BASED CONCURRENT CHEMORADIATION Roche Ongoing ATEZOLIZUMAB (TECENTRIQ) 2 MO43156 King Fahad Specialist Hospital (Dammam)
A randomized, sham-controlled, double-blind study to evaluate the efficacy and safety of intrathecal (IT) OAV101 in patients with later onset Type 2 spinal muscular atrophy (SMA) who are ≥ 2 to < 18 years of age, treatment naive, sitting, and never ambulatory Novartis Saudi Limited Ongoing OAV101 (formerly AVXS-101) 3 COAV101B12301 King Faisal Specialist Hospital and Research Center (Riyadh),King Fahad Specialist Hospital (Dammam)
Timing Of Thyroxine Dose In Ramadan KAIMRC Ongoing Levothyroxine 4 ICT22J/001 King Abdulaziz Medical City NG (Jeddah)
Fluids in septic shock (FISSH) KAIMRC Ongoing RINGER'S-LACTATE SOLUTION 3 SCT21R/001/01 King Abdulaziz Medical City NG (Riyadh)
Phase II study of neoadjuvant hormonal therapy guided by interval Ki67 testing in hormonal receptor-positive, HER2-negative breast cancer. King Abdullah Medical City (Makkah) Ongoing Letrozole (Femaplex) 2 20-718 King Abdullah Medical City (Makkah)
Modern Treatment of Inhibitor-PositiVe PATiEnts with Haemophilia A – An International Low-Interventional Pragmatic Investigator Initiated Trial Octapharma AG Ongoing Octanate, Wilate, Hemlibra, NovoSeven, Feiba 4 MOTIVATE King Abdulaziz Medical City NG (Riyadh)
Phase 1b/2 Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia Onyx Therapeutics, Inc., an Amgen Inc. Subsidiary Ongoing Carfilzomib 2 20140106 King Fahad Medical City (Riyadh)
View 81 - 90 From 701